The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of the EZH2 inhibitor tazemetostat in pediatric subjects with relapsed or refractory INI1-negative tumors or synovial sarcoma.
 
Susan N. Chi
No Relationships to Disclose
 
Geoffrey Brian McCowage
Research Funding - Epizyme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Lindsey Hoffman
No Relationships to Disclose
 
Margaret Macy
Stock and Other Ownership Interests - Johnson & Johnson; Teva; Varian Medical Systems
 
Susan Doleman
Employment - Epizyme
Stock and Other Ownership Interests - Amgen
 
Stephen J Blakemore
Employment - Epizyme; Takeda
Stock and Other Ownership Interests - Epizyme; Takeda
Patents, Royalties, Other Intellectual Property - Epizyme; Takeda
Travel, Accommodations, Expenses - Epizyme; Takeda
 
Alicia Clawson
Employment - Epizyme; Mallinckrodt
Stock and Other Ownership Interests - Epizyme
 
Scott Daigle
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
Patents, Royalties, Other Intellectual Property - Patents Relating to Pinometostat methods of use including combination and indications
Travel, Accommodations, Expenses - Epizyme
 
Jeanie Tang
Employment - Epizyme
 
Maria Roche
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Peter T.C. Ho
Employment - Epizyme
Leadership - Epizyme
Stock and Other Ownership Interests - Epizyme
Consulting or Advisory Role - Aileron Therapeutics
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline